Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2015

Open Access 01.12.2015 | Case Report

Successful palliation for an aged patient with primary pericardial mesothelioma

verfasst von: Ryutaro Isoda, Hiromichi Yamane, Shintaro Nezuo, Yasumasa Monobe, Nobuaki Ochi, Yoshihiro Honda, Satoshi Nishimura, Maki Akiyama, Takeshi Horio, Nagio Takigawa

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

An 85-year-old Japanese man with a complaint of exertional dyspnea was admitted to our hospital. Sixty-three years prior to admission at our hospital, he handled asbestos for 2 years in a factory. His chest computed tomography showed a massive pericardial effusion leading to cardiac tamponade and right pleural plaque. After a pericardiocentesis was performed, he recovered from cardiac failure caused by the cardiac tamponade. Pathological examination of the pericardial effusion revealed malignant mesothelial cells. Therefore, he was diagnosed with primary pericardial mesothelioma (PPM) related to asbestos exposure. Although his disease slowly progressed over 18 months, he remained active without any adjuvant treatments such as chemotherapy. Long-term palliation in an aged patient with PPM is rarely obtained using supportive care alone because the prognosis of PPM has been consistently reported to be very poor and almost fatal within a year. Clinical oncologists and thoracic surgeons should be aware of this disease because the accumulation of knowledge on PPM may lead to successful treatment even in aged patients.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12957-015-0692-5) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RI, HY, SNe, SNi, MA, NO, YH, and TH were involved in the clinical care of the patient and interpretation and analysis of clinical findings. YM performed immunohistochemistry and pathologically made the final diagnosis. RI, HY, and NT wrote and drafted the manuscript. All authors read and approved the final manuscript.
Abkürzungen
CEA
carcinoembryonic antigen
CT
computed tomography
PPM
primary pericardial mesothelioma
WT1
Wilms’ tumor 1

Background

Primary pericardial mesothelioma (PPM) is an extremely rare malignant neoplasm that arises from the pericardial mesothelial cell layers [1]. The incidence of PPM has been reported to be lower than 0.0022 % on an autopsy series [2]. The prognosis of PPM, which is usually unresectable, is very poor and almost consistently fatal [3]. Although no standard treatment has been established for this disease entity, subxiphoid pericardiostomy followed by drainage may be a safe procedure to provide effective and durable symptomatic relief in critically ill patients [3]. Here, we report an unusual clinical case, wherein a pericardiocentesis led to long-term palliation in a patient with PPM.

Case presentation

An 85-year-old man with 30 pack-year history of smoking presented to our hospital with a complaint of chest discomfort and exertional dyspnea persisting since a month. He had suffered myocardial infarction 9 years prior to this episode. He had worked as a gardener for about 40 years. Prior to becoming a gardener, he handled asbestos for 2 years in a factory. An electrocardiogram on admission revealed sinus tachycardia of 110 beats per minute. We observed a mild deterioration of his oxygen saturation to 93 % on room air with effort. His chest computed tomography (CT) revealed a massive pericardial effusion and bilateral mild pleural effusions without any tumors; these findings likely eliminated the diagnoses of primary lung cancer and metastatic carcinomas (Fig. 1a). In addition, right pleural plaques were clearly observed on chest CT after 8 months (Fig. 1b and Additional file 1: Figure S1). Cardiac ultrasonography also showed a massive pericardial effusion that caused a cardiac tamponade. A needle pericardiocentesis was immediately performed. The total amount of removed pericardial fluid was 2300 mL. This fluid was a bloody exudate with a specific gravity of 1.032. The chest discomfort and dyspnea markedly improved after the pericardiocentesis. To maintain the improvements in his symptoms, we initiated the administration of loop diuretics (20 mg/day). No further drainage or invasive approaches were performed to control the pericardial effusion.
The carcinoembryonic antigen (CEA) level in the pericardial effusion was 3.3 ng/mL. Pathological examination of the cell-block specimen obtained from the pericardial effusion revealed malignant mesothelial cells (Fig. 2a), which were positively stained with calretinin, D2-40, and Wilms’ tumor 1 (WT1) (Fig. 2bd, respectively). Furthermore, the cells were positively stained for p53 and epithelial membrane antigen and negatively stained for CEA (data not shown). Thus, he was diagnosed with PPM. Considering his age, he did not receive any chemotherapy. To date, only a loop diuretic has been administered for controlling the pericardial effusion. He was discharged on the 20th day of hospitalization. Chest CT 8 (Fig. 1c) and 16 months (Fig. 1d) later revealed that the pericardial effusion was well controlled. Although his symptoms of general fatigue and trunk pain slowly but steadily progressed and the pericardial effusion slightly increased, he remained fully active 18 months after his initial presentation.

Discussion

The treatments for PPM are surgical therapy, radiotherapy, and chemotherapy. Most of the surgical therapy comprises pericardial resection even when the tumor is localized. It is mostly useful for preventing cardiac tamponade or for tumor reduction [4]. Systemic chemotherapy with the combination of platinum and pemetrexed or the combination of doxorubicin, vincristine, and cyclophosphamide has been found to be effective for PPM in some reports [57]. The condition is usually fatal within a year regardless of its treatment being successful [3]. To the best of our knowledge, PPM is a rare disease entity and no reliable clinical trials for systemic chemotherapy have been conducted. The effectiveness of systemic chemotherapy had been demonstrated mainly through case reports. Because no large-scale clinical randomized trial of chemotherapy or radiotherapy for PPM has been performed yet, the evidence level for these treatments is rather low. Therefore, although neither radiation therapy nor chemotherapy has proven to be beneficial, both have been used as adjuvant treatments in patients with incomplete tumor resection or metastatic disease. In the present case, because of the patient’s age and the risk of adverse events caused by chemotherapy, we performed best supportive care alone. The patient remained fully active 18 months after his initial presentation.
The cell-block specimen obtained from his pericardial effusion was positively stained for calretinin, D2-40, and WT1 and negatively stained for CEA. Because mesothelioma cells do not have a specific marker for diagnosis, it is very difficult to make an adequate cytological diagnosis among the types of pulmonary adenocarcinoma cells. In general, useful diagnostic mesothelial markers include calretinin, WT1, cytokeratin 5/6, and D2-40. It has been recommended that at least two mesothelial markers and two carcinoma markers with greater than 80 % sensitivity and specificity be used for the diagnosis of mesothelioma when all clinical, radiologic, and histologic features are concordant [8].
These findings indicated that the pericardial tumor cells of this patient resembled epithelial mesothelioma (EM). EM generally has a good prognosis compared to sarcomatoid and biphasic mesothelioma. In particular, well-differentiated papillary mesothelioma, a rare variant of EM, is associated with a good prognosis owing to its clinically indolent behavior and long survival period [9]. Although definite reasons for the long survival time were not clear, we speculated that this favorable outcome could be obtained because of the properties of the tumor in this case.
The cause of PPM remains unknown, unlike that of pleural mesothelioma. Although the pathogenesis of PPM may not be related to asbestos exposure, Warren et al. reported that PPM was likely to develop during childhood and among patients with low levels of exposure to asbestos [3]. Mensi et al. reported a high incidence of occupational asbestos exposure among seven patients with PPM (5/7 patients: 71.4 %, 95 % CI 29.0–96.3) [10]. The asbestos exposure may be one of the main causes of PPM. Although PPM generally occurs in young people (median age, 46 years; range, 19–76) compared to pleural or peritoneal mesothelioma [11, 12], our case was an aged patient. Although his occupational asbestos exposure had lasted for only 2 years when he was young, pleural plaques detected on chest CT suggested that his disease was related to asbestos exposure.

Conclusions

In conclusion, this aged patient with PPM experienced an indolent clinical course with a long-term palliation after pericardiocentesis and loop diuretics. Because PPM is very rare, reporting the concise course of the disease will contribute to the accumulation of clinical knowledge.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Acknowledgements

We thank Ms. Naomi Fukushima, Research Assistant of Department of General Internal Medicine 3, Kawasaki Medical School, who performed the English editing of this manuscript.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RI, HY, SNe, SNi, MA, NO, YH, and TH were involved in the clinical care of the patient and interpretation and analysis of clinical findings. YM performed immunohistochemistry and pathologically made the final diagnosis. RI, HY, and NT wrote and drafted the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest. 1983;77:321–43.CrossRefPubMed Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest. 1983;77:321–43.CrossRefPubMed
2.
Zurück zum Zitat Cohen JL. Neoplastic pericarditis. Cardiovasc Clin. 1976;7:257–69.PubMed Cohen JL. Neoplastic pericarditis. Cardiovasc Clin. 1976;7:257–69.PubMed
3.
Zurück zum Zitat Warren WH. Malignancies involving the pericardium. Semin Thorac Cardiovasc Surg. 2000;12:119–29.CrossRefPubMed Warren WH. Malignancies involving the pericardium. Semin Thorac Cardiovasc Surg. 2000;12:119–29.CrossRefPubMed
4.
Zurück zum Zitat Eren NT, Akar AR. Primary pericardial mesothelioma. Curr Treat Options Oncol. 2002;3:369–73.CrossRefPubMed Eren NT, Akar AR. Primary pericardial mesothelioma. Curr Treat Options Oncol. 2002;3:369–73.CrossRefPubMed
5.
Zurück zum Zitat Doval DC, Pande SB, Sharma JB, Rao SA, Prakash N, Vaid AK. Report of a case of pericardial mesothelioma with liver metastases responding well to pemetrexed and platinum based chemotherapy. J Thorac Oncol. 2007;2:780–1.CrossRefPubMed Doval DC, Pande SB, Sharma JB, Rao SA, Prakash N, Vaid AK. Report of a case of pericardial mesothelioma with liver metastases responding well to pemetrexed and platinum based chemotherapy. J Thorac Oncol. 2007;2:780–1.CrossRefPubMed
6.
Zurück zum Zitat Santos C, Montesinos J, Castanar E, Sole JM, Baga R. Primary pericardial mesothelioma. Lung Cancer. 2008;60:291–3.CrossRefPubMed Santos C, Montesinos J, Castanar E, Sole JM, Baga R. Primary pericardial mesothelioma. Lung Cancer. 2008;60:291–3.CrossRefPubMed
7.
8.
9.
Zurück zum Zitat Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol. 2013;24:2147–50.CrossRefPubMed Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol. 2013;24:2147–50.CrossRefPubMed
10.
Zurück zum Zitat Mensi C, Giacomini S, Sieno C, Consonni D, Riboldi L. Pericardial mesothelioma and asbestos exposure. Int J Hyg Environ Health. 2011;214:276–9.CrossRefPubMed Mensi C, Giacomini S, Sieno C, Consonni D, Riboldi L. Pericardial mesothelioma and asbestos exposure. Int J Hyg Environ Health. 2011;214:276–9.CrossRefPubMed
11.
Zurück zum Zitat Restrepo CS, Vargas D, Ocazionez D, Martínez-Jiménez S, Betancourt Cuellar SL, Gutierrez FR. Primary pericardial tumors. Radiographics. 2013;33:1613–30.CrossRefPubMed Restrepo CS, Vargas D, Ocazionez D, Martínez-Jiménez S, Betancourt Cuellar SL, Gutierrez FR. Primary pericardial tumors. Radiographics. 2013;33:1613–30.CrossRefPubMed
Metadaten
Titel
Successful palliation for an aged patient with primary pericardial mesothelioma
verfasst von
Ryutaro Isoda
Hiromichi Yamane
Shintaro Nezuo
Yasumasa Monobe
Nobuaki Ochi
Yoshihiro Honda
Satoshi Nishimura
Maki Akiyama
Takeshi Horio
Nagio Takigawa
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2015
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-015-0692-5

Weitere Artikel der Ausgabe 1/2015

World Journal of Surgical Oncology 1/2015 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.